TENX: LeoPARDS Trial Fails Endpoints; Year End 2016 Readout for LEVO-CTS.
Yahoo! Finance USA,
By John Vandermosten, CFA Tenax Updates Trial Progress On October 5, 2016, Tenax Therapeutics, Inc.
By John Vandermosten, CFA Tenax Updates Trial Progress On October 5, 2016, Tenax Therapeutics, Inc.
By John Vandermosten, CFA NASDAQ:TENX Tenax Reports Second Quarter 2016 Results On August 9, 2016, Tenax Therapeutics, Inc.
By John Vandermosten, CFA NASDAQ:TENX Anti-LIGHT monoclonal antibody Research by Dr.
By 2 hours ago By John Vandermosten, CFA NASDAQ:TENX WHAT’S NEW Tenax Reports Abbreviated 2015 Financial Results Tenax…